ESR1 and breast carcinoma: Similar to S100A8, S100A9 expression was significantly upregulated in ER- (P < 0.0001), PR- (P < 0.0001), Her2+ (P = 0.00097) breast cancer (Fig. 5E) (Additional file 1: Table S2).